Life Is About To Change Forever: Immortality, AI, Elon Musk, Sam Altman, Crypto & Economic Collapse | Dr. Greene PT 1
Dr. Bill Greene, a biotech investor, discusses breakthrough opportunities in aging research, focusing on fibrosis reversal, epigenome manipulation, and the role of AI in drug discovery. He emphasizes that success in biotech requires investing in exceptional people who can iterate through failures while remaining data-driven, and argues that understanding aging's fundamental mechanisms—rather than trying to achieve immortality—should be the primary goal.
Summary
In this wide-ranging conversation about longevity and biotech investment, Dr. Bill Greene outlines his investment thesis for companies tackling diseases of aging. He identifies fibrosis—the buildup of connective tissue that restricts organ function—as a particularly promising target for reversal, noting that researchers are actively exploring connections between chronic inflammation and fibrotic processes. Greene explains that the critical difference between biotech and tech investing is that biology involves genuine uncertainty; even with perfect science and engineering, clinical outcomes remain unknown until tested in humans.
Greene emphasizes that successful biotech entrepreneurs must combine the typical entrepreneurial traits (vision, drive, organizational ability) with specific biological competencies: tolerance for risk, data-driven decision-making, and willingness to accept that biology may contradict initial hypotheses. He describes his evaluation process as focusing heavily on how individuals respond to adversity and failure, looking for those with a "no job is too small" service mindset and genuine obsession about their mission. Evolution's investment strategy deliberately provides patient capital to support companies through multiple iterations, recognizing that traditional venture capital timelines are often too short for biological breakthroughs.
The conversation explores the hallmarks of aging in depth. Greene articulates established hallmarks—DNA damage, epigenetic changes, protein misfolding, impaired autophagy, and mitochondrial dysfunction—and discusses emerging ones like loss of intrinsic capacity and cognitive decline. He positions epigenetic dysregulation (improper methylation and gene expression) as particularly central to aging, distinct from accumulated DNA mutations. A Harvard study showing that mice predisposed to DNA breaks don't accumulate mutations but instead experience de-differentiation supports the epigenome hypothesis.
Regarding AI's role, Greene views it as a tool for reducing complexity rather than replacing experimental biology. He argues that while AI excels at pattern recognition and predicting outcomes from existing data, it cannot replace the fundamental human need to make novel observations and conduct experiments that generate new ground-truth data. Scientists will always be needed to satisfy curiosity and test hypotheses that algorithms cannot independently generate. He describes AI as "fixed ropes" on a mountain—essential guidance but not the complete solution.
The discussion ventures into philosophy regarding simulation, consciousness, and determinism. Greene acknowledges that humans create subjective simulations in their minds but maintains belief in objective reality and deterministic physics. He agrees that achieving true immortality at the organism level would likely require de-differentiation (as with the Turritopsis dohrnii jellyfish) that would erase memory and identity, making it an undesirable goal. He reframes the objective as healthspan rather than lifespan—living with vitality and minimal chronic disease rather than indefinite existence.
Greene envisions AI eventually enabling the creation of molecular machines that can traverse chromosomes, identify DNA damage with precision, and repair it before pathological consequences occur—a capability far beyond current gene-editing approaches that have off-target effects. He positions this vision as discovery rather than rule-changing, arguing that fundamental laws of physics are immutable but our understanding of how biological systems operate within those laws is incomplete and evolving.
The conversation emphasizes first-principles thinking as essential to progress, using Elon Musk as an example of someone who exemplifies this approach: identifying goals, recognizing obstacles, hypothesizing solutions, testing through iteration, and adjusting based on data rather than ego. Greene notes this methodology applies directly to both biotech development and investment evaluation.
About this episode
<p>Welcome to another thought-provoking episode of Impact Theory, I’m Tom Bilyeu! </p><p>Today I’m joined by Dr. Bill Greene, Chief Investment Officer at Hevolution Foundation, a non-profit organization that provides grants and investments in healthspan science. Dr. Greene is in the thick of it when it comes to using science and medicine to drive positive change in unhealthy aging. </p><p>Dr. Greene is here to answer difficult questions on the explosive potential of AI in medicine, the ethical minefields of today's health practices and insurance, and the foundations of health, economy, and the ethical fabric of society.</p><p><br /></p><p>In this discussion, we touch on: </p><ul> <li>Investments & advancements in biotechnology </li> <li>The hallmarks of the complex aging processes </li> <li>Potential applications of AI in drug discovery</li> <li>Increasing lifespan, improving health span, and preventing diseases</li> <li>First Principles thinking in progress and innovation </li> </ul><p><br /></p><p>Are we on the brink of a new era in human health and longevity, or are we playing with a Pandora's box that could implode our understanding of humanity?</p><p>This is just Part 1 of our conversation, so make sure you don’t miss Part 2 of this convo for even more insights from Dr. Bill Greene.</p><p><br /></p><p><strong>Follow Dr. Greene:</strong></p><p>Website: https://hevolution.com/</p><p>LinkedIn: https://www.linkedin.com/in/william-greene-83846/</p><p><br /></p><p><strong>Follow Me, Tom Bilyeu: </strong></p><p>Website: https://impacttheoryuniversity.com/ </p><p>X: https://twitter.com/TomBilyeu</p><p>Instagram: https://www.instagram.com/tombilyeu/</p><p><br /></p><p>SPONSORS:</p><p><em>If you purchase an item using these affiliate links, Impact Theory may receive a commission.</em> </p><p>Get 5 free AG1 Travel Packs and a FREE 1 year supply of Vitamin D with your first purchase at <a href="https://bit.ly/AG1Impact" target="_blank">https://drinkag1.com/impact</a>.</p><p>Try Audible free for 30 days! Just visit <a href="https://ad.doubleclick.net/ddm/trackclk/N265001.5142112IMPACTTHEORY/B31093336.383876618;dc_trk_aid=575313582;dc_trk_cid=207284465;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;ltd=;dc_tdv=1" target="_blank">https://audible.com/impacttheory</a> or text impacttheory to 500-500.</p><p>This episode is sponsored by Betterhelp. Give online therapy a try at <a href="https://betterhelp.com/impacttheory" target="_blank">https://betterhelp.com/impacttheory</a> and get on your way to being your best self!</p><p>ButcherBox is offering our listeners their choice of a weeknight meal essential— 3 lbs of chicken thighs, 2 lbs of ground beef, or 1 lb of premium steak tips — for free in every order for a whole year, plus, get $20 off your first order at <a href="https://butcherbox.com/impact" target="_blank">https://butcherbox.com/impact</a> and use code IMPACT to choose your free offer and get $20 off.</p><p>Sign up for a one-dollar-per-month trial period at <a href="https://shopify.com/impact" target="_blank">https://shopify.com/impact</a> now to grow your business – no matter what stage you’re in.</p><p>Right now get 55% off your Babbel subscription - but only for our listeners - at <a href="https://babbel.com/IMPACTTHEORY" target="_blank">https://babbel.com/IMPACTTHEORY</a>.</p><p>Head to <a href="https://squarespace.com/impact" target="_blank">https://squarespace.com/impact</a> for a free 14 day trial and 10% off your first purchase of a website or domain.<strong> </strong></p><p>Secure your digital life with proactive protection for your assets, identity, family, and tech – Go to <a href="https://aura.com/IMPACT" target="_blank">https://aura.com/IMPACT</a> to start your free two-week trial.</p><p>Take control of your gut health by going to <a href="https://tryviome.com/impact" target="_blank">https://tryviome.com/impact</a> and use code IMPACT to get 20% off your first 3 months and free shipping.</p><p><br /></p><p><strong><em>***Are You Ready for EXTRA Impact?***</em></strong></p><p>If you’re ready to find true fulfillment, strengthen your focus, and ignite your true potential, the Impact Theory subscription was created just for you. </p><p><strong>*New episodes delivered ad-free, EXCLUSIVE access to hundreds of archived Impact Theory episodes, Tom AMAs, and so much more!*</strong></p><p>This is not for the faint of heart. This is for those who dare to learn obsessively, every day, day after day.</p><p><br /></p><p><strong>*****Subscribe on Apple Podcasts: </strong><a href="https://apple.co/3PCvJaz" target="_blank">https://apple.co/3PCvJaz</a>*****</p><p><br /></p><p><strong>Subscribe on all other platforms</strong> (Google Podcasts, Spotify, Castro, Downcast, Overcast, Pocket Casts, Podcast Addict, Podcast Republic, Podkicker, and more) : <a href="https://impacttheorynetwork.supercast.com/" target="_blank">https://impacttheorynetwork.supercast.com/</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices" target="_blank">megaphone.fm/adchoices</a></p><p>See Privacy Policy at <a href="https://art19.com/privacy" rel="noopener noreferrer" target="_blank">https://art19.com/privacy</a> and California Privacy Notice at <a href="https://art19.com/privacy#do-not-sell-my-info" rel="noopener noreferrer" target="_blank">https://art19.com/privacy#do-not-sell-my-info</a>.</p>
Key Insights
- Greene argues that fibrosis was long considered irreversible, but emerging research into the inflammatory-to-fibrotic pathway suggests reversal may be possible, potentially unlocking resilience in aging organs.
- He claims that biotech investing fundamentally differs from tech investing because biology contains irreducible uncertainty—even perfect science and engineering cannot guarantee clinical success until tested in humans.
- Greene asserts that the epigenome (gene expression control through methylation) rather than accumulated DNA mutations is the primary mechanism of aging, supported by studies showing mice predisposed to DNA breaks don't accumulate mutations but experience de-differentiation.
- He contends that exceptional people are the determinant factor in biotech success, more so than science alone, because they can navigate uncertainty, reframe failed experiments as learning, and adjust course when biology contradicts assumptions.
- Greene identifies a pattern he looks for in leaders: those who respond to failure by taking time to reflect, identifying alternative paths, and committing to new strategies—rather than dismissing failure or repeating unsuccessful approaches.
- He argues that AI serves primarily as a complexity-reduction tool and pattern-recognition engine, not as a replacement for experimental biology, because algorithms require ground-truth data that only novel experiments can generate.
- Greene maintains that human curiosity—the ability to ask 'I wonder what would happen if' without logical precedent—remains irreplaceable by AI and is essential for discovering novel therapeutic approaches.
- He claims that true biological immortality at the organism level would require complete de-differentiation (like the Turritopsis jellyfish), which would necessarily erase memory and identity, making it philosophically undesirable.
- Greene argues that the actual goal should be healthspan (living with vitality and minimal chronic disease) rather than lifespan extension, reflecting what most people genuinely want.
- He contends that manipulating fundamental biology is possible not by violating physics but by discovering more complete understanding of how biological systems operate within immutable physical laws.
- Greene asserts that Evolution's strategy of providing multi-iteration patient capital fills a market gap where traditional venture capital timelines are too short for biological breakthroughs to prove themselves.
- He claims that future AI-enabled therapeutics may create molecular machines capable of scanning chromosomes for damage and performing precise repairs in a way far more targeted than current gene-editing approaches with off-target effects.
Topics
Transcript
You are living in the most disruptive time in human history. Given the advances in AI and biotechnology, you might have to contend with the possibility of human immortality. It's certainly not a guarantee, but advances in healthspan, anti-aging, and cellular biology make it one of the most important conversations of our time. Investments and decisions made now will reverberate for generations to come. here to talk about the state of Affairs is Dr Bill Green you as an investor have a very difficult job and as an investor you have to bet against the consensus and be right so what I want to know is what is it that you really believe in in your specialty of biotech that…
Full transcript available for MurmurCast members
Sign Up to AccessMore from Tom Bilyeu's Impact Theory
This Isn't Just Technology — It's A Weapons Race — We Had To React
This video analyzes whether AI is in a bubble by examining the massive capital expenditures of hyperscalers, comparing current debt-to-value ratios (4%) to the dot-com era (30%), and weighing bullish arguments about AI as a critical arms race against bearish concerns about revenue growth, Chinese competition, and public sentiment.
Manufacturing Comeback, Data Center Miracles & The Collapse of U.S. Education: What’s Really Happening? | Tom Bilyeu Show
Tom Bilyeu discusses America's fiscal crisis with a $432.3 billion July deficit and $931 billion in annual interest payments, explores why socialist economic proposals are mathematically impossible to fund, and examines failures in American education where high school seniors cannot read or write—highlighting the need for cultural revitalization, market discipline, and educational accountability.
This One Bread Story Explains Why Every Planned Economy Collapses — We Had To React
An in-depth analysis of why planned socialist economies consistently collapse, using the Berlin Wall experiment as a central case study. The video traces economic history from feudalism through capitalism to socialism, explaining how price signals and decentralized decision-making drive market efficiency, while centralized planning creates information problems, perverse incentives, and eventual authoritarianism.
NVIDIA’s $500 Billion Gamble, A.I. Doctor Revolution, & Rent Strikes Gone Wild | The Tom Bilyeu Show
The episode discusses several pressing issues, including NVIDIA's AI financing strategies and the implications of AI developments in healthcare. It also touches on rent strikes and leftist activism, with a critical examination of political narratives surrounding economic systems.
The Banks Aren't Holding The AI Financial Risk — The Public Is — We Had To React
The discussion revolves around the financial risks of AI investments, particularly in companies like OpenAI and Anthropic, highlighting their unprofitable nature and the systemic risks posed by their financing structures. The conversation emphasizes the potential consequences for the public and the economy if these companies fail to deliver on their promised growth.